Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: Evidence for distinct cellular origin

Blood

Volumn 89, Issue 3, 1997, Pages 980-989

  Krenacs, Laszlo ^b   Wellmann, Axel ^b   Sorbara, Lynn ^b   Himmelmann, Andreas W ^b   Bagdi, Eniko ^b   Jaffe, Elaine S ^b   Raffeld, Mark ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; GRANZYME B; PERFORIN;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CELL STRUCTURE; CHILD; CLINICAL ARTICLE; CYTOTOXIC LYMPHOCYTE; FEMALE; GENE EXPRESSION; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MALE; NATURAL KILLER CELL; NULL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 0030944428     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.3.980     Document Type: Article

References (60)

1. Timonen T, Ortaldo JR, Herberman RB: Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med 153:569, 1981
2. Grossi CE, Zicca A, Cadoni A, Mingari MC, Moretta A, Moretta L: Ultrastructural characteristics of human T cell clones with various cytolytic activities. Eur J Immunol 13:670, 1983
3. Koizumi H, Liu CC, Zheng LM, Joag SV, Bayne NK, Holoshitz J, Young JD: Expression of perforin and serine esterases by human gamma/delta T cells. J Exp Med 173:499, 1991
4. Nakata M, Smyth MJ, Norihisa Y, Kawasaki A, Shinkai Y, Okumura K, Yagita H: Constitutive expression of pore-forming protein in peripheral blood gamma/delta T cells: Implication for their cytotoxic role in vivo. J Exp Med 172:1877, 1990
5. Griffiths GM, Mueller C: Expression of perforin and granzymes: In vivo potential diagnostic markers for activated cytotoxic cells. Immunol Today 12: 415, 1991
6. Peters PJ, Borst J, Oorschot V, Fukuda M, Krahenbuhl O, Tchopp J, Slot JW, Geuze HJ: Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med 173:1099, 1991
7. Nakata M, Kawasaki A, Azuma M, Tsuji K, Matsuda H, Shinkai Y, Yagita H, Okumura K: Expression of perforin and cytolytic potential of human peripheral blood lymphocyte subpopulations. Int Immunol 4:1049, 1992
8. Hudig D, Ewoldt GR, Woodard SL: Proteases and lymphocyte cytotoxic killing mechanisms. Curr Opin Immunol 5:90, 1993
9. Henkart PA: Lymphocyte-mediated cytotoxicity: Two pathways and multiple effector molecules. Immunity 1:343, 1994
10. Su B, Bochan MR, Hanna WL, Froelich CJ, Brahmi Z: Human granzyme B is essential for DNA fragmentation of susceptible target cells. Eur J Immunol 24:2073, 1994
11. Anderson P, Nagler-Anderson C, O' Brien C, Levine H, Walkins S, Slayter HS, Blue ML, Schlossman SF: A monoclonal antibody reactive with a 15 kd cytoplasmic granule associated protein defines a subpopulation of CD8+ T lymphocytes. J Immunol 144:574, 1990
12. Tian Q, Streuli M, Saito H, Schlossman SF, Anderson P: A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell 67:629, 1991
13. Anderson P. TIA-1: Structural and functional studies on a new class of cytolytic effector molecule. Curr Top Microbiol Immunol 198:131, 1995
14. Stalder T, Hahn S, Erb P: Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J Immunol 152:1127, 1994
15. Takeshita M, Kimura N, Suzumiya J, Ohshima K, Kikuchi M, Watanabe R, Okamura T, Goto H: Angiocentric lymphoma with granulomatous panniculitis in the skin expressing natural killer cell and large granular T-cell phenotypes. Virchows Arch 425:499, 1994
16. De Bruin PC, Kummer JA, Van der Valk P, Van Heerde P, Kluin PM, Willemze R, Ossenkoppele GJ, Radaszkiewicz T, Meijer CJ: Granzyme B-expressing peripheral T-cell lymphomas: Neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localization. Blood 84:3785, 1994
17. Martin AR, Chan WC, Perry DA, Greiner TC, Weisenburger DD: Aggressive natural killer cell lymphoma of the small intestine. Mod Palhol 8:467, 1995
18. + T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 87:1466, 1996
19. Cooke CB, Krenacs L, Stetler-Stevenson M, Greiner TC, Raffeld M, Kingma DW, Abruzzo L, Frantz C, Kaviani M, Jaffe ES: Hepatosplenic T cell lymphoma: Distinct clinicopathologic entity of cytotoxic γδ origin. Blood 88:4265, 1996
20. Loughran TP: Clonal diseases of large granular lymphocytes. Blood 82:1, 1993
21. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles TM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
22. Jaffe ES, Chan JK, Su IJ, Frizzera G, Mori S, Feller AC, Ho FC: Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 20:103, 1996
23. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848, 1985
24. O'Connor NT, Stein H, Gatter KC, Wainscoat JS, Crick J, Al Saati T, Falini B, Delsol G, Mason DY: Genotypic analysis of large cell lymphomas which express the Ki-1 antigen. Histopathology 11:733, 1987
25. Herbst H, Tippelmann G, Anagnostopoulos I, Gerdes J, Schwarting R, Boehm T, Pileri S, Jones DB, Stein H: Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma: Dissociation between phenotype and genotype. Leuk Res 13:103, 1989
26. Ohshima K, Kikuchi M, Masuda Y, Yoshida T, Mohtai H, Eguchi F, Kimura N, Takihara Y: Genotypic and immunophenotypic analysis of anaplastic large cell lymphoma (Ki-1 lymphoma). Pathol Res Pract 186:582, 1990
27. Jaffe ES: Post-thymic T-cell lymphomas, in Major Problems in Pathology: Surgical Pathology of the Lymph Nodes and Related Organs. vol 16. Philadelphia, PA, Saunders, 1994, p 344
28. Kaudewitz P, Stein H, Dallenbach F, Eckert F, Bieber K, Burg G, Braun-Falco O: Primary and secondary cutaneous Ki-1+ (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic and clinical characteristics. Am J Pathol 135:359, 1989
29. De Bruin PC, Beljaards RC, Van Heerde P, Van der Valk P, Noorduyn LA, Van Krieken JHJM, Kluin-Nelemans JC, Willemze R, Meijer CJLM: Differences in clinical behavior and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. Histopathology 23:127, 1993
30. + lymphoproliferative disorders: Comparison with anaplastic large-cell lymphoma of nodal origin. Blood 87:3437, 1996
31. Rimokh R, Magaud JP, Berger F, Samarut J, Coiffier B, Germain D, Mason DY: A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (Ki-1 lymphoma). Br J Haematol 71:31, 1989
32. Mason DY, Bastard C, Rimokh R, Dastugue N, Huret JL, Kristoffersson U, Magaud JP, Nezelof C, Tilly H, Vannier JP, Hemet V, Warnke R: CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35. Br J Haematol 74:161, 1990
33. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1281, 1994
34. + anaplastic large cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. Blood 86:2321, 1995
35. Leoncini L, Del Vecchio MT, Kraft R, Megha T, Barbini P, Cevenini G, Poggi S, Pileri S, Tosi P, Cottier H: Hodgkin's disease and CD30-positive anaplastic large cell lymphomas - A continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study. Am J Pathol 137:1047, 1990
36. Noorduyn LA, De Bruin PC, Van Heerde P, Van de Sandt MM, Ossenkoppele GJ, Meijer CJ: Relation of CD30 expression to survival and morphology in large cell B cell lymphomas. J Clin Pathol 47:33, 1994
37. Mason DY, Cordell J, Brown M, Pallesen G, Ralfkiaer E, Rothbart J, Crumpton M, Gatter KC: Detection of T cells in paraffin wax embedded tissue using antibodies against a peptide sequence from the CD3 antigen. J Clin Pathol 42:1194, 1989
38. Stansfeld AG, Diebold J, Kapanci Y, Kelenyi G, Lennert K, Mioduszewska O, Noel H, Rilke F, Sundstrom C, Van Unnik JA, Wright D: Updated Kiel classification for lymphomas. Lancet 1:292, 1988 (letter)
39. Van Gorp J, Weiping L, Jacobse K, Liu YH, Li FY, De Weger RA, Li G: Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in western China. J Pathol 173:81, 1994
40. Beckstead JH: Improved antigen retrieval in formalin-fixed, paraffin-embedded tissues. Appl Immunohistochem 2:274, 1994
41. De Bruin PC, Noorduyn AL, Van der Valk P, Van Heerde P, Van Diest PJ, Van de Sandt MM, Ossenkoppele GJ, Meijer CJ: Noncutaneous T-cell lymphomas. Recognition of a lymphoma type (large cell anaplastic) with a relatively favorable prognosis. Cancer 71:2604, 1993
42. Kinney MC, Collins RD, Greer JP, Whitlock JA, Sioutos N, Kadin ME: A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma. Am J Surg Pathol 17:859, 1993
43. Pileri S, Falini B, Delsol G, Stein H, Baglioni P, Poggi S, Martelli MF, Rivano MT, Mason DY, Stansfeld AG: Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/ Ki-1+ with a high content of reactive histiocytes). Histopathology 16:383, 1990
44. Banks PM, Metter J, Allred DC: Anaplastic large cell (Ki-1) lymphoma with histiocytic phenotype simulating carcinoma. Am J Clin Pathol 94:445, 1990
45. Yowell R, Hammond E: Ki-1 lymphoma: A case report. Ultrastruct Pathol 16:11, 1992
46. Kawasaki A, Shinkai Y, Kuwana Y, Furuya A, Iigo Y, Hanai N, Itoh S, Yagita H, Okumura K: Perforin, a pore-forming protein detectable by monoclonal antibodies, is a functional marker for killer cells. Int Immunol 2:677, 1990
47. Shinkai Y, Yoshida MC, Maeda K, Kobata T, Maruyama K, Yodoi J, Yagita H, Okumura K: Molecular cloning and chromosomal assignment of a human perforin (PRF) gene. Immunogenetics 30:452, 1989
48. Leger-Ravet MB, Devergne O, Peuchmaur M, Solal-Celigny P, Brousse N, Gaulard P, Galanaud P, Emilie D: In situ detection of activated cytotoxic cells in follicular lymphomas. Am J Pathol 144:492, 1994
49. Devergne O, Raphael M, Autran B, Leger-Ravet MB, Coumbaras J, Crevon MC, Galanaud P, Emilie D: Intratumoral activation of CD8-positive cytotoxic lymphocytes in acquired immunodeficiency syndrome lymphomas. Hum Pathol 26:284, 1995
50. Oudejans JJ, Kummer JA, Jiwa M, Van der Valk P, Ossenkoppele GJ, Kluin PM, Kluin-Nelemans JC, Meijer CJ: Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease. Am J Pathol 148:233, 1996
51. Shikano T, Ishikawa Y, Naito H, Kobayashi R, Nakadate H, Hatae Y, Takeda T: Cytogenetic characteristics of childhood non-Hodgkins lymphoma. Cancer 70:714, 1992
52. Bullrich F, Morris SW, Hummel M, Pileri S, Stein H, Croce CM: Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas. Cancer Res 54:2873, 1994
53. Sandlund JT, Pui CH, Roberts WM, Santana VM, Morris SW, Berard CW, Hutchison RE, Ribeiro RC, Mahmoud H, Crist WM, Heim M, Raimondi SC: Clinicopathologic features and treatment outcome of children with large-cell lymphoma and the t(2;5)(p23;q35). Blood 84:2467, 1994
54. Downing JR, Shurtleff SA, Zielenska M, Curcio-Brint AM, Behm FG, Head DR, Sandlund JT, Weisenburger DD, Kossakowska AE, Thorner P, Lorenza A, Ladanyi M, Morris SW: Molecular detection of the (2;5) translocation of non-Hodgkins lymphoma by reverse transcriptase-polymerase chain reaction. Blood 85:3416, 1995
55. Weisenburger DD, Gordon BG, Vose JM, Bast MA, Chan WC, Greiner TC, Anderson JR, Sanger WG: Occurrence of the t(2;5)(p23;q35) in non-Hodgkins lymphoma. Blood 87:3860, 1996
56. Arber DA, Sun L-H, Weiss LM: Detection of the t(2;5)(p23;q35) chromosomal translocation in large B-cell lymphomas other than than anaplastic large cell lymphoma. Hum Pathol 27:590, 1996
57. Yee HT, Ponzoni M, Merson A, Goldstein M, Scarpa A, Chilosi M, Menestrina F, Pittaluga S, de Wolf-Peeters C, Shiota M, Mori S, Frizzera G, Inghirami G: Molecular characterization of the t(2;5) (p23; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease. Blood 87:1081, 1996
58. Berke G: The binding and lysis of target cells by cytotoxic lymphocytes: Molecular and cellular aspects. Annu Rev Immunol 12: 735, 1994
59. Verret CR, Firmenich AA, Kranz DM, Eisen HN: Resistance of cytotoxic T lymphocytes to the lytic effects of their toxic granules. J Exp Med 166:1536, 1987
60. Liu CC, Jiang S, Persechini PM, Zychlinsky A, Kaufmann Y, Young JD: Resistance of cytolytic lymphocytes to perforin-mediated killing. Induction of resistance correlates with increase in cytotoxicity. J Exp Med 169:2211, 1989